Immediate Impact

9 by Nobel laureates 9 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

De novo protein design—From new structures to programmable functions
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
1 intermediate paper

Works of Yong Ren being referenced

Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study
2017
Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein
2013

Author Peers

Author Last Decade Papers Cites
Yong Ren 298 195 126 163 15 615
Anne Vroon 460 213 138 138 16 737
Sooyeon Jo 420 178 48 161 31 704
Katherine A. Peebles 307 126 139 253 14 723
Sebastian Stösser 300 136 91 231 20 718
Lindsey Hudson 283 199 65 392 8 726
Ewa Bałkowiec-Iskra 109 113 79 117 29 636
Ho K. Lee 311 64 44 134 12 689
D. Minocci 164 118 133 74 16 588
Changxiong Guo 113 78 96 164 17 636
Zheng Chang 212 103 56 131 22 628

All Works

Loading papers...

Rankless by CCL
2026